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Abstract
Introduction The tissues of the laryngeal region only rarely harbor primary cartilaginous lesions, and squamous cell carci-
noma remains the most frequently encountered malignant tumor in this area.
Materials and Methods We reviewed the salient histological features of cartilaginous laryngeal lesions to provide differential 
diagnostics and guidelines for distinguishing the benign from the malignant ones.
Results Cartilaginous neoplasms of the larynx include chondroma and chondrosarcoma. Among the overarching group of all 
forms of laryngeal sarcoma, chondrosarcoma forms the most common entity in the larynx, followed by rhabdomyosarcoma. 
Cartilaginous tumors comprise about 0.1%–1% of all laryngeal neoplasms with chondrosarcomas being more frequently 
encountered than chondromas. Several neoplasms earlier reported as giant-cell tumors of the larynx would most likely, using 
current terminology, be classified as cases of undifferentiated pleomorphic sarcoma (previously known as malignant fibrous 
histiocytoma, giant-cell variant) or aneurysmal bone cyst.
Conclusion When true laryngeal sarcomas do exist, they may prove to be challenging lesions both for the pathologist and the treat-
ing clinician. The diagnostic problems are mainly a result of the infrequent exposure of clinicians and diagnosticians to these lesions.
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Chondrometaplasia
Definition and epidemiology
Among the family of the cartilaginous lesions of the lar-
ynx, chondrometaplasia appears to be the most frequently 
encountered entity. One early autopsy report described an 
incidence of asymptomatic laryngeal chondrometaplasia 
somewhere in the range of 1.2–1.7/100,000 people who died 
of a variety of causes and were subsequently autopsied [1]. 
This particular human autopsy study was prompted by those 
authors’ earlier identification of similar chondrometaplastic 
lesions in both vocal cords of a male orangutan [2]. The 
incidence of symptomatic chondrometaplasia encountered by 
clinicians may be higher or lower, e.g., a report by Burtner 
et al. reported that chondrometaplasia was found in 9% of all 
vocal cord polyps in surgical pathology material reviewed 
over a 2-year period [2].
Etiology
The cause of chondrometaplasia is not known with cer-
tainty. In one report, almost 80% of symptomatic individuals 
had previously undergone endotracheal intubation, raising 
the possibility that this may be a post-traumatic lesion in 
at least some—perhaps even a majority of—patients [2]. 
Other patients in this series had been treated with prior 
received radiotherapy, while yet other patients were smok-
ers. One autopsy study suggested that the histologic fea-
tures of developing chondrometaplasia proceed through a 
predictable series of steps. This involves deposition of acid 
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mucopolysaccharides amongst the collagen bundles in the 
soft tissues of the false vocal cord, followed by a ‘rounding 
up’ of the appearance of the fibroblast nuclei, then leading 
to an appearance of myxoid stromal change in the region, 
and finally culminating in a proliferation of fibroelastic car-
tilage [1].
Pathology
The gross specimen of chondrometaplasia resembles the 
commonly encountered vocal cord polyp, in that it is typi-
cally small (less than one centimeter in diameter), round 
to oval, and covered by mucosa; this mucosa is most often 
intact, without ulceration. On cut section, a glistening, gray-
white nodule is found in the center of the lesion—an appear-
ance which contrasts with that of the soft, red-tan, fibro-
vascular core which usually forms the center of the more 
commonly encountered vocal cord polyp.
By light microscopy, chondrometaplastic lesions are 
immediately recognizable as cartilaginous in nature, as 
indicated by their arrangement of isolated cells residing 
within lacunae, which are widely spaced in a basophilic or 
eosinophilic matrix. The individual nuclei are small, single, 
homogenously dark, and lack mitotic activity. The key his-
tological feature of chondrometaplasia, however, relates not 
to the individual cells which form the lesion but rather to 
the elastic cartilage matrix in which they are embedded [3].
In addition, a gradual blending of the elastic cartilage 
stroma into the surrounding fibrous stroma is often seen 
by light microscopy. This finding contrasts with the better 
defined, sharp distinction between the hyaline cartilage of a 
true chondroma and its surrounding stroma. This “transition 
zone” in chondrometaplasia is marked by a contrast between 
centrally located rounded nuclei situated within lacunae and 
the progressively flattened cells, more reminiscent of fibro-
blast nuclei, found at the periphery of the lesion.
Aside from the use of histochemical staining for elastin 
to highlight the elastic cartilage nature of the matrix, it is 
unlikely that a surgical pathologist will be forced to rely 
upon ancillary diagnostic techniques, such as immunohis-
tochemical or ultrastructural studies, to confirm a diagnosis 
of chondrometaplasia.
Clinical features
Laryngeal chondrometaplasia appears both in symptomatic 
patients typically complaining of a change in their phona-
tion, and in asymptomatic patients (in this instance, usually 
discovered at the time of clinical evaluation of an unrelated 
problem or at autopsy). Those patients who complained of 
hoarseness reported having had symptoms for an average of 
7 months prior to clinical examination [2]. The incidence 
of chondrometaplasia seems to be slightly greater in males 
than in females. Chondrometaplasia is, in general, a lesion 
of adulthood; however, although it has not been reported in 
patients during the first decade of life, it has been described 
in patients ranging in age from the second decade of life 
to the tenth, with an average age at presentation of around 
52 years [2, 4–7]. In the majority of cases, chondrometapla-
sia arises in the vocal cords and less often in the epiglottic 
region [3, 7, 8].
The lesions may be solitary or multiple and may affect 
one or both sides of the larynx. Symptomatic lesions usu-
ally occupy the region of the true vocal cords followed in 
incidence by the epiglottis and the ventricle. By contrast, 
incidentally discovered asymptomatic lesions of laryngeal 
chondrometaplasia are usually located in the area of the false 
vocal cords.
Pathologists are familiar with the finding of metaplas-
tic changes within laryngeal tissues, e.g, they commonly 
encounter often witness squamous metaplasia in the res-
piratory epithelium, or osseous metaplasia in cartilage (the 
latter is often a concomitant of aging and may be seen in 
the structures composed of hyaline cartilage, including the 
cricoid cartilage, thyroid cartilage and the body of the aryt-
enoid cartilage).
Diagnosis and differential diagnosis
Symptomatic laryngeal chondrometaplastic lesions are usu-
ally biopsied at the time of direct laryngoscopy and sub-
mitted as “vocal cord polyps”. The asymptomatic lesions 
are more often encountered by the surgical pathologist at 
the time of dissection of a laryngectomy specimen resected 
for another process (most often squamous carcinoma), or at 
autopsy. Whether single or multiple, the nodules of chondro-
metaplasia rarely exceed 1 cm in greatest dimension.
Recognition of both the small size of the lesions and their 
elastic stroma will aid in distinction of these lesions from 
laryngeal chondromas and chondrosarcomas. Care should 
be taken not to confuse chondrometaplasia with the normal 
elastic cartilaginous components of the larynx. Of substan-
tial assistance to the surgical pathologist in this regard is the 
clinical identification by the surgeon of the nodules of chon-
drometaplasia as an abnormal growth within the laryngeal 
region. The epiglottis, corniculate cartilage and cuneiform 
cartilage are composed of elastic cartilage but are unlikely to 
be confused with nodules of chondrometaplasia. In addition, 
the vocal process of the arytenoid is also composed of elastic 
cartilage and its nodular appearance may invite comparison 
with chondrometaplasia. The arytenoid vocal processes are 
sharply circumscribed nodules of elastic cartilage and are 
not marked by the transition zone (from elastic cartilage to 
adjacent stroma) often found in lesions of chondrometapla-
sia. Moreover, the normal arytenoid vocal process is unlikely 
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to be submitted by a surgeon as a “polyp” in a patient with 
hoarseness.
Treatment and prognosis
Chondrometaplasia is a benign, presumably reactive process. 
It has neither been shown to have a metastatic potential nor 
has it been shown to be a direct cause of death in a given 
patient. Local excision is the treatment of choice. No prema-
lignant potential has been ascribed to this lesion. Occasional 
recurrences have been reported but re-excision appears to be 
curative in these instances [7]. It is for this reason—the typi-
cal clinical course—that chondrometaplasia should be sepa-
rated from the neoplastic chondromas and chondrosarcomas, 
as the latter two lesions are more likely to behave in a more 
aggressive fashion than chondrometaplasia. Of course, in the 
view of the proposed etiology of the lesion—that of a reac-
tive process—it is conceivable that, should the inciting cause 
(such as trauma for example) persist following excision of 
a nodule of laryngeal chondrometaplasia, recurrent lesions 
may well continue to develop; in practice however, this does 
not appear to be a very common occurrence (Table 1).
Chondroma
Definition and epidemiology
Chondromas are benign mesenchymal tumors—true neo-
plasms, and not reactive processes. Earlier reports of laryn-
geal chondromas may have included some lesions better 
classified as laryngeal chondrometaplasia and others which 
probably represented low-grade chondrosarcomas. Neverthe-
less, benign proliferations of hyaline cartilage do occur in 
the larynx and so, a true chondroma may enter the surgical 
pathologist’s differential diagnosis of both chondrometapla-
sia and low-grade chondrosarcoma.
A critical review of chondroma cases is virtually impos-
sible, because most reports lack pathological documentation 
and follow-up data. Chondroma of the larynx is considered 
uncommon and occurs most frequently in males, usually in 
middle age. Traves is credited with the first description of 
this lesion in the larynx in 1816 [9]. Accounts of cases in 
which a diagnosis of primary chondroma was followed by the 
diagnosis of chondrosarcoma for the recurrent tumor raise the 
very real possibility that (supposing some degree of confusion 
between benign chondromas and low-grade chondrosarcomas 
might have existed) the incidence of chondroma may well 
have been been overestimated, making true laryngeal chon-
dromas extremely rare [10]. Only two cases of laryngeal chon-
droma were seen at the Mayo Clinic between 1910 and 1979 
among a total of 33 cartilaginous tumors of the larynx [11]. 
Of the 323 cases of benign neoplasms of the larynx reviewed 
from the pathology files of the Eye and Ear Hospital and Pres-
byterian University Hospital of Pittsburgh, dating from 1955 
to 1984, only two cases were observed [12]. Several cases 
reported as chondromas have been subsequently described 
as chondrosarcomas. This, in turn, suggests that chondroma 
and chondrosarcoma either are capable of appearing synchro-
nously in the same tumor or metachronously through a malig-
nant transformation from chondroma to chondrosarcoma; as 
is often the case in other low-grade mesenchymal tumors—
atypical lipomatous tumor (low-grade liposarcoma), e.g., it is 
likely that a single tumor may show both areas recognizable as 
low-grade chondrosarcoma as well as areas not recognizable 
in isolation as malignant, which speaks loudly to the need 
for thorough sampling of cartilaginous tumors of the larynx.
Etiology
The specific cause of these tumors is not known. Neither 
trauma (as in some instances of chondrometaplasia) nor 
therapeutic irradiation (as in some chondrosarcomas) have 
been implicated in the formation of laryngeal chondromas.
Pathology
Both biopsy and definitive excision specimens share a com-
mon gross appearance, namely, that of proliferation of nod-
ules of homogenous gray-white translucent tissue with a 
rubbery, slippery texture. Foci of hemorrhage or necrosis 
should not be found on gross examination.
On low-power light microscopic examination, chondro-
mas usually have a multinodular architecture. The individual 
Table 1  Key features of a laryngeal chondrometaplasia
Relatively common (perhaps as many as 9% of symptomatic vocal cord polyps, 1.2–1.7% at autopsy)
Symptomatic i.e. change in phonation (vocal cords, epiglottis, ventricle), or asymptomatic (false vocal cords)
Adults (average age 52 years, symptomatic patients)
Size usually less than 1 cm in diameter
Elastic cartilage; small homogeneous nuclei, no mitoses
Differential diagnosis—chondroma
Transition zone (chondroid center, spindle periphery)
Recurrences rare following excision, no metastatic potential
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tumor cell nuclei show a distinct degree of uniformity, one 
to another—they are mostly single nuclei with homogenous 
dark chromatin set in lacunae; cytological nuclear details are 
largely obscured. It must be conceded that there is a degree 
of subjectivity in this requirement; it has been found for 
example, that a minimal degree of cytological atypia in the 
extraosseous lesions of synovial chondromatosis is not in 
itself incompatible with a benign diagnosis. However, when 
dealing with laryngeal lesions the pathologist is best advised 
to adhere to the rather stricter criteria employed in the rec-
ognition of intraosseous chondrosarcomas (i.e., a lower 
threshold for recognizing atypia as significant), instead of 
the somewhat more liberal standards sometimes applied to 
soft tissue lesions such as synovial chondromatosis.
The cellularity of chondroma is lower than that of at least 
some areas of low-grade chondrosarcomas—that is to say, 
if chondrosarcomas include some 30 or 40 cells per high-
power field in the most cellular areas, then the cellularity of 
chondromas should fall short of that. It has to be repeated, 
however, that cellularity and atypia may vary from area to 
area within a chondrosarcoma, and so the pathologist should 
not be lulled into a false sense of security by a cursory 
inspection of a few areas in a cartilaginous lesion. Mitotic 
figures are not a feature of the typical chondroma which 
means that finding mitotic figures in a presumed chondroma 
specimen should prompt reconsideration of the possibility 
that the lesion might in fact be a chondrosarcoma.
Ideally, a large and intact specimen of chondroma will 
show relatively broad interfaces of chondroid tumor with the 
adjacent tissues, and an absence of an infiltrative pattern (the 
latter is more commonly a feature of more aggressive lesions 
such as a chondrosarcoma). However, this may be difficult to 
appreciate in specimens consisting of a multitude of small 
disparate tumor fragments.
Islands of chondroid tumor may be partially surrounded 
by enveloping bands of thin bony trabeculae; the cells form-
ing these osseous trabeculae are cytologically benign, and 
so confusion with osteosarcoma should not arise. Arising 
as, presumably, a degenerative phenomenon, islands of 
chondromatous tissue may undergo central calcification or 
ossification. These processes are not accompanied by cyto-
logically malignant cells and should thus not invite confu-
sion with sarcomatous degeneration in an otherwise benign 
chondroma.
As the cartilaginous nature of this lesion is readily recog-
nized with routinely stained histological preparations, it is 
unlikely that the surgical pathologist will rely on ancillary 
diagnostic techniques (such as ultrastructural studies) to con-
firm a diagnosis of chondroma. It remains to be established 
whether other methods or markers associated with prolifera-
tive activity (such flow cytometry, or immunohistochemi-
cal staining for an antigen such as proliferating cell nuclear 
antigen) will aid in making the distinction of chondroma 
from low-grade chondrosarcoma of the larynx.
Clinical features
The cricoid cartilage is most often the site of origin of laryn-
geal chondroma, followed in turn by thyroid cartilage, the 
epiglottis, and the body of the arytenoid [13]. In the case 
of a particularly large chondroma, it may be difficult to 
determine the tumor’s site of origin. Laryngeal chondromas 
are typically symptomatic lesions, presenting with airway 
obstruction and manifesting as dyspnea or as a mass in the 
neck region.
Diagnosis and differential diagnosis
These tumors may be solitary or multiple and can arise 
from any hyaline cartilage of the laryngeal skeleton. The 
neoplasm resembles the histology of normal cartilage, but 
modestly increased cellularity may be seen. In contrast to 
lesions of chondrometaplasia (whose small size usually pre-
cludes their detection via imaging studies), chondromas may 
be studied radiographically to gauge their size and extent 
prior to surgical exploration. Plain films often disclose the 
presence of a homogeneous soft tissue density, which may 
show areas of punctate or ring-like calcifications. These cal-
cifications may be highlighted on CT scans and MR scans, 
studies which may aid in precisely delineating the extent of 
the tumor.
Biopsy may be complicated by the rubbery-hard con-
sistency of the chondroid lesion, which may resist gentle 
attempts at harvesting tissue for diagnosis. The following 
two key differential diagnostic possibilities are deserving 
of consideration whenever a pathologist is considering the 
diagnosis of laryngeal chondroma—one benign, the other 
malignant. Chondrometaplasia has been confused in the 
past with true chondromas of the larynx. However, when 
symptomatic, chondrometaplasia is usually localized to the 
vocal cords (in contrast to the chondromas, which most often 
appear in the vicinity of the cricoid cartilage), and it consists 
of an elastic cartilaginous matrix (as opposed to the hyaline 
cartilage of a true chondroma). The other differential diag-
nostic consideration—from the other end of the biological 
spectrum—is that of laryngeal chondrosarcoma. Some chon-
drosarcomas are high-grade lesions and easily recognized as 
malignant and thus, do not pose a major diagnostic problem. 
The low-grade chondrosarcomas, however, are notorious—
both within the bone as well as in an extraosseous site such 
as the larynx—for the frequency with which they are mis-
diagnosed by the unwary as benign proliferations. Of some 
aid in addressing this problem in intraosseous sites is the 
radiographic appearance of the lesion, but such radiographic 
clues are not always as helpful in a laryngeal lesion. This 
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will place an even greater burden on the surgical pathologist 
to interpret the tissue fragments correctly.
For the sake of completeness, there is one final differen-
tial diagnostic consideration, albeit a singularly rare one. 
Hamartomas—seen most often in pediatric patients, less 
often in adults—may be encountered in the larynx [14–17]. 
In its broadest sense, the term hamartoma refers to a space 
occupying lesion composed of normal mature cells/tissues 
arranges in an abnormal architecture. Not true neoplasms, 
hamartomas are regarded as developmental abnormalities. 
As a matter of light microscopy, an (exceedingly rare) laryn-
geal hamartoma with cartilaginous differentiation might be 
expected to incorporate mature cartilage, respiratory epithe-
lium, muscular tissue, or other tissues—albeit in an unusual 
architecture, the chief tip-off to a diagnosis of hamartoma.
In summary, key features of the histology of low-grade 
chondrosarcoma should be excluded before settling on a 
diagnosis of chondroma. Specifically, a chondroma should 
not show evidence of nuclear enlargement, atypia, or mitotic 
activity. The (subjective) finding of increased cellular-
ity should also prompt consideration of the possibility of 
a low-grade chondrosarcoma, and so force the pathologist 
to search for other histological clues (such as cytology and 
mitotic activity) on which to base a final diagnosis. While 
some have attached some ominous significance to a finding 
of binucleate cells in a chondroid lesion, this change alone 
may be encountered in benign lesions and should not be 
relied on a marker for malignancy. Foci of myxoid change in 
the cartilaginous stroma, while not themselves diagnostic of 
malignancy, are certainly more commonly seen in malignant 
than in benign lesions. As a result, their identification in 
what otherwise is apparently a chondroma should prompt the 
pathologist to investigate the biopsy specimen more closely 
for cytological features that may indicate that the lesion has 
potential for more aggressive behavior.
As a general principle, the pathologist should be wary 
of making a diagnosis of chondroma in any incompletely 
sampled lesion of the larynx. Should a biopsy yield only 
tissue fragments of a cartilaginous lesion that lacks the his-
tological features of malignancy, it would be wise to ensure 
that the specimen in question is not simply an incisional 
biopsy from a much larger lesion. In such a setting—a lim-
ited sampling of a larger cartilaginous lesion in which malig-
nant features are not found—one diagnosis, which may be 
entertained is that of a “cartilaginous lesion of the larynx, 
not further subclassified”. This might be accompanied with 
a comment stating that, while malignant features cannot be 
found in the present lesion, sampling of the entire lesion (if 
excision is technically possible) is recommended for precise 
classification.
The aforementioned considerations will no doubt invite 
some criticism from the attending surgeon, who would 
desire a firm diagnosis in order to plan surgical therapy. 
However, the pathologist can only remind the clinicians 
that examining one small snapshot from of a complex, het-
erogeneous lesion will not always predict the appearance of 
other (yet unsampled) regions, which means that one may 
be dealing with an occult low-grade malignancy which has 
not yet been adequately sampled. Variation in the histologi-
cal pattern within the same lesion—from areas diagnostic 
of chondroma to areas diagnostic of chondrosarcoma—is a 
recognized phenomenon, which should enhance the patholo-
gist’s natural suspicion regarding the appearance of any por-
tion of a tumor, which has not yet been exhaustively sam-
pled. As a general rule, the larger the lesion the more likely 
it is to be malignant.
Treatment and prognosis
Chondromas are more amenable to surgical resection than 
are the low-grade chondrosarcomas arising in the same 
region. One potential complication of surgical therapy is 
postoperative laryngeal stenosis; stenosis usually follows a 
more extensive resections, particularly of cricoid lesions. It 
is in view of this potential complication of extensive ther-
apy (as well as the potential for compromising the anatomic 
integrity of the larynx, thus forcing the surgeon to perform 
a total laryngectomy) that the surgeon will understand-
ably be reluctant to perform more extensive surgery than 
is absolutely necessary. This will, predictably, bring addi-
tional pressure to bear on the pathologist to make a binding 
distinction of benign from malignant at the time of biopsy 
sampling of a larger lesion. True laryngeal chondromas 
may attain sizes of a few centimeters in diameter, but do not 
metastasize (Table 2).
Chondrosarcoma
Definition and epidemiology
Chondrosarcomas are malignant mesenchymal tumors typi-
fied by the elaboration of a chondroid matrix by the malig-
nant tumor cells. Chondrosarcomas are most often thought 
of as skeletal tumors—they comprise some 20% of skel-
etal malignancies. By contrast, chondrosarcomas are rarely 
encountered in the head and neck; when they do arise in 
the head and neck region, the larynx is one of the most fre-
quently affected sites. In the past, chondroma and chondro-
sarcoma have sometimes been grouped under the unifying 
category of “cartilaginous tumors”; in modern practice, 
however, it is critically important to distinguish the two neo-
plasms as well as the morphological variants of chondrosar-
coma because their biological behaviors are actually quite 
divergent. In the older literature laryngeal chondroma was 
more commonly encountered than chondrosarcoma, whereas 
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the application of current diagnostic criteria makes the exist-
ence of convincing reports of true laryngeal chondromas 
quite a rarity.
New was the first to use the term ’chondrosarcoma of 
the larynx’ in 1935 [18]. A host of terms have since been 
applied for this neoplastic lesion, such as non-calcifying 
chondrosarcoma, malignant chondroma, dedifferentiated 
chondrosarcoma, chondrosarcoma with malignant mes-
enchymal component, extraskeletal chondrosarcoma, and 
extra-osseous chondrosarcoma (Table 3).
Arriving at an accurate estimation of the incidence of 
laryngeal chondrosarcoma is seriously hampered by the fact 
that in the early reports describing cartilaginous tumors in 
this region, low-grade chondrosarcomas were almost cer-
tainly mistaken for benign chondromas in some instances. 
Still, chondrosarcoma (and not fibrosarcoma, as was thought 
to be the most common laryngeal sarcoma by some observ-
ers in the past) appears to be the most frequent sarcoma of 
the larynx. According to the review by Rinaldo et al. [19] 
approximately 600 cases were reported in the literature 
up till 2000. The review by Chin et al. tabulated 592 pub-
lished cases [20]. The North-American SEER data report 
by Dubal et al. include 143 cases between 1973 and 2010 
[21]. Thompson and Gannon reported 111 cases diagnosed 
between 1970 and 1997 registered in the Otorhinolaryngol-
ogy—Head & Neck Tumor Registry of the Armed Forces 
Institute of Pathology [22]. The largest series belongs to 
the Armed Forces Institute of Pathology, Washington DC 
with 240 cases registered from 1929 to 1999 [23]. Table 4 
summarizes the largest series (series with more than five 
cases) of laryngeal chondrosarcoma reported in the world.
Pathology
Gross pathology
The surgical specimen from a laryngeal chondrosarcoma 
resection specimen may have a highly variable gross appear-
ance, largely as a function of the tumor’s histological grade. 
The tumor presents as a lobulated submucosal, rounded or 
oval mass covered by laryngeal mucosa. The neoplasm may 
be uniformly hard or may have soft and even cystic areas of 
degeneration. Even in the more advanced stages, the tumor 
tends to develop within the laryngeal hyaline cartilage and 
only rarely extends beyond the external perichondrium to 
invade the surrounding tissues (surrounding tissue invasion 
is more often found in recurrent lesions). The maximum 
dimension of the tumor usually ranges 1–6 cm, although 
massive lesions which the larynx are sometimes observed.
Histopathology
Chondrosarcomas can be classified as low-grade (grade I), 
intermediate-grade (grade II) or high-grade (grade III) chon-
drosarcomas. Most laryngeal chondrosarcomas are low- or 
intermediate-grade tumors. The histological pattern of low-
grade chondrosarcoma is marked by some degree of over-
lap with the histologic pattern of a benign chondroma—a 
distinct pitfall for the unwary pathologist. The neoplasm is 
Table 2  Key features of a laryngeal chondroma
Rare lesions. May be less common than laryngeal chondrosarcoma, but the true incidence is difficult to judge from older reports in which the 
distinction from chondrometaplasia and low-grade chondrosarcoma may sometimes have been imperfect
Symptomatic lesions cause airway obstruction or a palpable mass in the neck
Usually found in the vicinity of the cricoid cartilage, thyroid cartilage, epiglottis, and arytenoids
May be a few cm in diameter and usually smaller than a laryngeal chondrosarcoma
Hyaline cartilage, small, monomorphous nuclei without significant nuclear details, no mitoses
No transition zone (in contrast to chondrometaplasia)
Differential diagnosis: chondrometaplasia, low-grade chondrosarcoma (and, most rarely, laryngeal hamartomas)
May recur following excision, but this is uncommon, no metastatic potential
Table 3  The differential 
diagnosis of chondrometaplasia 
and chondroma of the larynx
Chondrometaplasia Chondroma
Symptoms Hoarseness or asymptomaticr Obstruction of the airway or 
swelling of the neck
Gross presentation Small nodule < 1 cm in diameter Multilobular tumour
Gross presentation Ventricular fold and vocal cord Cricoid and thyroid cartilages
Type of cartilage Elastic Hyaline (usually)
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Table 4  The largest ( > 5 cases presented) published series of laryngeal chondrosarcoma
Series No. of cases Period Authors Year Remarks
University Hospital Heidelberg, 
Germany
7 2013–2018 Akbaba et al. [44] 2018 These cases were treated upfront 
with raster-scanned carbon ion 
Radiotherapy
Johns Hopkins, School of 
Medicine, Baltimore, USA
6 2004–2013 Karatayli-Ozgursoy et al. [45] 2016 All were of cricoid origin, three 
out of six had a recurrence
Guy’s and St Thomas’ NHS 
Foundation Trust, London, 
UK
5 1996–2012 Stavrakas et al. [46] 2016
Dept. of ORL, Turin, Rome, 
Belluno, Italy
6 2006–2013 Damiani et al. [47] 2014 All had conservative surgical 
approach
Centro Hospitalar e Universi-
tário de Coimbra, Portugal
6 2002–2012 Oliveira et al. [48] 2014 One had high grade, five under-
went total laryngectomy
Montpellier University Hospi-
tal, France
7 2001–2008 Pelliccia et al. [49] 2014 All had low-grade cricoid chon-
drosarcoma
University of Brescia, Italy 16 2001–2013 Piazza et al. [41] 2014 Eleven were of low grade and 
five of intermediate grade
Moffitt Cancer Institute USA 5 2004–2011 Jackson et al. [50] 2013 Four were of low grade and one 
of intermediate grade
Tel Aviv University, Israel 6 1959–2010 Buda et al. [51] 2012 Recurrence developed in two 
patients 2 and 8 years after 
primary treatment
Harvard Medical School USA 11 2002–2011 Friedman et al. [52] 2012 b
Harvard Medical School, USA 10 1995–2010 Zeitels et al. [53] 2011 Eight underwent conservation 
function preservation surgery
Croix-Rousse Hospital, France 7 1996–2006 Merrot et al. [54] 2009 All were of low grade
Institut Gustave-Roussy France, 
and M. D. Anderson Cancer 
Center, USA
15 1978–1997 Casiraghi et al. [25] 2004 One was of high grade
Wake Forest University, USA 9 1991–2002 Koufman et al. [55] 2004 All were cricoid and of low grade
Armed Forces, Institute of 
Pathology, USA
111 1970–1997 Thompson and Gannon [22] 2002 Only six were of high grade
Clermont-Ferrand University 
Medical Center, France
5 1981–1990 Saleh et al. [56] 2002 One was of high grade
One was myxoid type and pre-
sented with neck metastases
The Royal National Throat, 
Nose and Ear Hospital, UK
12 1976–1999 Rinaldo et al. [19] 2000 All were of low grade No metas-
tases
Armed Forces Institute of 
Pathology, USA
240 1929–1999 Dennis K. Heffner personal 
communication [23]
1999 This series includes the cases of 
Thompson and Gannon  2002a
University Hospital VU, 
Amsterdam
5 1980–1998 Tiwari et al. [57] 1999 One of the authors previously 
reported four cases of chondro-
sarcoma of the cricoid treated 
from 1985 to 1995 at the same 
institution. No lymph node or 
distant metastases
University of Kiel, Germany 5 1975–1995 Lippert et al. [58] 1997 One patient died of brain metas-
tases 3 months after surgery
Mayo Clinic, Minnesota, USA 44 1910–1995 Lewis et al. [59] 1997 All were of low grade. No lymph 
node or distant  metastasesc
University of Buenos Aires, 
Medical Center, Argentina
6 1973–1990 Sztern et al. [60] 1993 No lymph node or distant metas-
tases
Mallinckrodt Institute of Radi-
ology, Washington University 
Medical Center, USA
10 –d Wippold et al. [61] 1993 One was of thyroid origin, all 
were visible in CT scan
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composed of a relatively homogeneous stroma marked by 
basophilic (or, less often, metachromatic) staining with con-
ventional hematoxylin and eosin preparations. In turn, the 
individual tumor cells—the malignant chondrocytes—are 
embedded in that chondroid matrix in individual holes in 
that matrix ("lacunae"). Binucleated and occasionally even 
multinucleated cells may be found. In at least some areas of 
the tumor, features including irregular nuclear membranes 
and prominent nucleoli may be apparent, which serve to but-
tress a diagnosis of a malignant cartilaginous tumor. Mitoses 
are usually difficult to find in low-grade chondrosarcomas. 
Calcification and bone formation are frequent. As noted 
previously, most laryngeal chondrosarcomas are low-grade 
(well differentiated) tumors.
Medium-grade chondrosarcomas show increased cellular-
ity, particularly at the periphery of the lobules. The nuclear-
cytoplasmic ratio of the chondrocytes is, as a general rule, 
higher than that seen in benign chondromas and low-grade 
chondrosarcomas (i.e., cytoplasm is relatively diminished 
in respect to nucleus size). Plump binucleated cells are also 
seen. Mitoses, if present, are uncommon.
High-grade chondrosarcomas are rare [24]. This tumor 
type shows striking cellularity and cytologic atypia, and 
plump binucleated and multinucleated cells are often seen. 
The chondrocytes have large nuclei with nucleoli and deli-
cate chromatin, and the nuclear-cytoplasmic ratio is rela-
tively high. Mitoses are frequently seen.
One variant of chondrosarcoma, called dedifferenti-
ated chondrosarcoma, has also been reported in the lar-
ynx [25–27] (described by some authors as chondrosarco-
mas with additional malignant mesenchymal component 
(CAMMC)) [22]. This term describes a neoplasm in which 
a high-grade sarcomatous component is associated with 
a lower-grade cartilaginous component. This is a pattern 
which echoes the development of other soft tissue tumors, 
such as dedifferentiated liposarcoma. Two histological 
components comprise a dedifferentiated chondrosarcoma: 
islands of low-grade (grade 1 of 3, with foci of grade 2 tumor 
in some areas) chondrosarcoma, and a second (high grade) 
component. The high-grade sarcomatous component of a 
dedifferentiated chondrosarcoma may take the form of an 
undifferentiated pleomorphic sarcoma (formerly, malignant 
fibrous histiocytoma), fibrosarcoma, rhabdomyosarcoma, 
osteosarcoma, or sarcoma (not further classified). The 
lower grade islands of recognizable cartilaginous tumor are 
embedded in the high-grade component, with a sharp bor-
der separating the two components (rather than a gradual 
zone of transition). While a minority of the dedifferentiated 
chondrosarcomas have manifested initially as an apparently 
low-grade cartilaginous tumor, only showing evidence of 
a high-grade component at the time of a subsequent recur-
rence, most of the laryngeal dedifferentiated chondrosarco-
mas reported to date all appear to have been recognizable as 
such at the time of initial presentation [26].
Another morphological variant of chondrosarcoma 
occasionally found in the larynx is chondrosarcoma with 
extensive myxoid change (characterized by some authors 
as myxoid chondrosarcoma) [22, 28]. The reason for 
describing these lesions as chondrosarcomas with exten-
sive myxoid change, and not as myxoid chondrosarcomas, 
is related to the existence of a well-recognized soft tis-
sue tumor—the extraskeletal myxoid chondrosarcoma. 
Table 4  (continued)
Series No. of cases Period Authors Year Remarks
Mount Sinai School of Medi-
cine, New York City, USA
11 1973–1990 Brandwein et al. [26] 1992 Two cases were dedifferenti-
ated chondrosarcoma and one 
presented with cervical lymph 
node metastases
Depts. of ORL-HNS, Universi-
ties of Brescia (1) Padua (2) 
and New Haven (3)
8 1983–1989 (1) 
1966–1989 (2) 
1962–1989 (3)
Nicolai et al. [10] 1990 One case was dedifferentiated 
chondrosarcoma and the patient 
presented with lung metastases
Swedish Cancer Registry 6 1958–1972 Östberg et al. [62] 1979 No lymph node or distant metas-
tases
Chevalier Jackson Clinic, USA 10 1935–1970 Al-Saleem et al. [63] 1970 One patient presented with cervi-
cal lymph node metastasis
Massachusetts Eye and Ear 
Infirmary, USA
8 1940–1970 Huizenga and Balogh [64] 1970 One patient presented with lung, 
kidney, and neck metastases
a Thompson and Gannon [22]
b This series includes the 10 cases reported by Zeitels et al. [53] for the period 1995–2010
c This series includes previous published series (Goethals and Dahlin [65]; Gorenstein et al. [66]; Neel and Unni [11]; Kozelsky et al. [67])
d Six cases were from the series registered during the years 1970–1991 at the Armed Forces Institute of Pathology (AFIP) and therefore, these 
have been partially reported by Thompson and Gannon [22] and Heffner (personal communication 1999) [23]. Four additional cases with CT 
examinations were obtained from the teaching archives of the Mallinckrodt Institute of Radiology
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Extraskeletal myxoid chondrosarcomas are character-
ized by a balanced translocation, t(9;22)(q22;q12); in the 
absence of a demonstration of such a translocation in a 
particular laryngeal lesion with the appearances described 
below, it appears a prudent course to characterize such 
lesions as "chondrosarcomas with extensive myxoid 
change".
Chondrosarcomas with extensive myxoid change are 
characterized by nodular aggregations of relatively small, 
relatively monomorphous hyperchromatic tumor cells 
arranged in cords, trabeculae and small nests and set in 
an abundant basophilic homogenous myxoid material; 
tumor cell density is often greater at the peripheries of the 
nodules than in their centers. The tumor cells are usually 
polygonal with prominent nucleoli, but some spindling 
may occur as well. Mitotic figures are difficult to find in 
this tumor. Some minor degree of intracytoplasmic vacu-
olar change may be apparent, but the multiple large intra-
cellular vacuoles typical of the “physaliferous cells” of a 
chordoma are not characteristic of a chondrosarcoma with 
extensive myxoid change. A well-developed plexiform 
vascular pattern is absent. Recognizable cartilaginous 
areas may be scanty, and so close attention to the size, 
shape and architectural arrangement of the tumor cells is 
essential for the recognition of this tumor.
Clear-cell chondrosarcoma is another rare variant of 
chondrosarcoma, which may arise in the larynx. Laryngeal 
clear cell chondrosarcoma is characterized by the presence 
of large rounded cells with an abundance of clear cytoplasm 
and prominent nucleoli; often, interspersed multinucleated 
giant cells and bone trabeculae are present as well. Only a 
few cases of laryngeal chondrosarcoma have been described 
in the literature. It is a slow-growing tumor—usually a low-
grade tumor—and this necessitates a long-time follow-up of 
patients to monitor for recurrent disease. Due to the extreme 
rarity of this tumor in the head and neck region, a diagnosis 
of clear cell chondrosarcoma in this area should be con-
firmed by histochemical and immunohistochemical studies 
[29–35]. To date a laryngeal mesenchymal chondrosarcoma 
does not appear to have been reported. The histological fea-
tures of the laryngeal chondrosarcomas are summarized in 
Table 5.
Immunohistochemistry
Chondrosarcomas show positive staining for S-100 protein 
and vimentin. The dedifferentiated and myxoid chondrosar-
comas are also positive for S-100 protein.
Electronmicroscopy
Malignant chondrocytes will show slightly rounded appear-
ance with short processes and scalloping of the membrane. 
Binucleated cells are typical with nuclei expressing dis-
persed chromatin, and occasionally with large nucleoli. 
Abundant cytoplasm typically contains numerous branching 
segments of rough endoplasmic reticulum and a prominent 
Golgi apparatus [36, 37].
Clinical features
Laryngeal chondrosarcomas are most frequently encoun-
tered in patients between the age of 50 and 70, but they 
may also occur in the young. Chin et al. [20] reported an 
average age of 62.5 years for laryngeal chondrosarcomas at 
diagnosis (range 15–93); in a similar vein, Thompson and 
Gannon [22] found an average age at diagnosis of 64.4 years 
(range 25–91). The reported male-to-female ratio is 3:1 to 
4:1 [20, 22, 38]. The most common site of origin is the cri-
coid cartilage (75%)—particularly, its posterior lamina. Less 
frequently, there are reports of laryngeal chondrosarcomas 
arising in the thyroid cartilage, arytenoid cartilages, epi-
glottis and accessory cartilages. Rare reports of some chon-
drosarcomas that appear to have originated in the epiglottis 
exist, an observation that—if proven to be true—may cast 
some doubt on the commonly held notion that this tumor 
Table 5  Histologic subtypes of laryngeal chondrosarcomas
Low-grade chondrosarcoma (grade 1 of 3) (slight increase in cellularity, nuclear size, and nuclear detail over chondroma; no or rare mitoses)
Intermediate-grade chondosarcoma (grade 2 of 3) (distinct increase in cellularity, nuclear size, nuclear detail, and cytological atypia over chon-
droma, mitoses still difficult to find)
High grade chondrosarcoma (grade 3 of 3) (high cellularity , easily recognized cytological atypia; mitotic figures usually readily identified; 
areas may be difficult to recognize as cartilaginous, owing to exceedingly high cellularity and anaplasia of tumor cells)
Dedifferentiated chondrosarcoma (chondrosarcoma with additional malignant mesenchymal component) (CAMMC) (low-grade chondrosar-
comatous areas juxtaposed with high-grade sarcomatous area—undifferentiated pleomorphic sarcoma (malignant fibrous histiocytoma), 
fibrosarcoma, rhabdomyosarcoma, osteosarcoma, or sarcoma not further subclassified)
Chondrosarcoma with extensive myxoid change (nodules of monomorphous round to spindle cells arranged in cords, trabeculae and small 
clusters and set in a myxoid matrix; mitotic figures not readily identified) (note: tumors with this appearance that manifest a recipirocal 
t(9;22) translocation may be related to a recognized soft tissue tumor, the extraskeletal myoxid chondrosarcoma)
Clear cell chondrosarcoma (the tumor contains a component of balloon-like rounded cells with a predominantly clear cytoplasm and prominent 
nucleoli, in addition to multinucleated giant cells and bone trabeculae; the balloon-like clear cells are glycogen positive)
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arises only in hyaline and not in elastic cartilage. Chondro-
sarcoma may also involve the hyoid bone, but this is not 
anatomically a part of the larynx.
Symptoms of a laryngeal chondrosarcoma include pro-
gressive hoarseness, dyspnea and dysphagia, varying accord-
ing to tumor location. Dyspnea will predominate if the neo-
plasm extends anteriorly into the lumen of the airway. If it 
develops posteriorly into the pharynx, dysphagia will result. 
As the neoplasm is usually slow-growing, the patient may 
over time adapt to progressive narrowing of the airway, until 
an episode of acute inspiratory dyspnea leads to emergency 
tracheotomy [39]. When the neoplasm originates from the 
thyroid cartilage, the major complaint may be the presence 
of a hard lump in the neck produced by the tumor mass. As 
described in some cases reported in the literature, the first 
clinical sign may be vocal cord paralysis, apparently unas-
sociated with other laryngeal or non-laryngeal lesions and 
thus (initially) subject to misidentification as idiopathic in 
nature. In these cases, vocal cord paralysis is almost exclu-
sively an early sign of cricoid chondrosarcoma and may be 
related to involvement of the recurrent nerve or fixation of 
the cricoarytenoid joint.
On routine images of the neck, the neoplasm usu-
ally appears as a multilobulated mass marked by varying 
degrees of calcification. Computed tomography with con-
trast medium is useful both for demonstrating the extent of 
the lesion and for raising the possibility of a cartilaginous 
tumor in the first place. A lesion with calcified areas, exten-
sively involving one or more conventional cartilage bear-
ing regions that is marked by moderate enhancement on CT 
post contrast, is typical of a laryngeal cartilaginous tumor. 
However, there are no consistent, reproducible radiographic 
criteria to permit differentiation between chondrosarcoma 
and chondroma.
Magnetic resonance imaging can also demonstrate the 
lesion within the larynx and has the additional advantage of 
superior contrast resolution of the neoplasm and paralaryn-
geal tissues.
Chondrosarcoma of the larynx most often extends to local 
tissues although lymphogenous and haematogenous metas-
tases have been observed in 10% of the cases reported in the 
literature [22]. When distant spread does occur, lungs and 
lymph nodes are most frequently involved. Other metasta-
ses have occurred in kidney, spleen, cervical spine [37] and 
occasionally in the humerus [40].
Diagnosis and differential diagnosis
Both the submucosal location and the rubbery consistency of 
laryngeal cartilaginous lesions combine to frustrate attempts 
at securing an adequate biopsy sampling of cartilaginous 
lesions. It is advisable to obtain the biopsy sample under 
general anaesthesia and it may be necessary to perform 
a preliminary tracheotomy to obtain easier access to the 
lesion. Laryngeal chondrosarcomas often contain areas with 
different degrees of differentiation, so that only a generous 
biopsy sample will provide a reliable picture of the tumor’s 
diagnostic macroscopic/microscopic features. Rare reports 
of diagnosis of laryngeal chondrosarcoma by way of needle 
biopsy under CT scan guidance have been published.
The distinction between benign and malignant varieties of 
cartilaginous neoplasms of the larynx is challenging. Cases 
reported in the literature as benign chondromas, which were 
actually laryngeal chondrosarcomas, are not uncommon and 
a correct diagnosis could not be established until a recur-
rence or metastases developed. In addition, there is no con-
sensus on the subject of the transformation of chondroma 
to chondrosarcoma remains questionable, whether a tumor 
with areas reminiscent of chondroma intermixed with areas 
recognizable as chondrosarcoma represents a chondrosar-
coma arising in a pre-existing chondroma, or whether it a 
single lesion with varying differentiation? The authors favor 
the latter interpretation but acknowledge that this dilemma 
remains open for further research.
To reliably establish a distinction between benign and 
malignant cartilaginous lesions, attention should be con-
centrated more on the component of existing cells than 
on the intercellular matrix. In better-differentiated exam-
ples, a malignancy should be suspected in the presence of 
many cells with plump nuclei, more than just occasional 
cells with two such nuclei, giant cartilage cells with large, 
single or multiple nuclei or with irregular clumps of chro-
matin. Nuclear irregularity and the prominence of nucleoli 
are additional features suggestive of a malignancy. Mitoses 
are usually scanty. Lobularity may represent a microscopic 
feature of malignancy, with the periphery of lobules often 
marked by high cellularity and cytological irregularities. 
Proliferative activity of cells (as might be highlighted, for 
example, by immunohistochemistry with antibody to Ki-67) 
may provide an aid in the distinguishing of chondroma and 
highly-differentiated chondrosarcoma. The differential diag-
nostic possibility of a chondroblastic osteosarcoma warrants 
consideration; areas of calcification and non-neoplastic bone 
may be present in chondrosarcoma but, unlike in osteosar-
coma, bone formation by the cytologically malignant tumor 
cells is not seen in chondrosarcoma.
Depending on the light-microscopic appearances of the 
case, differential diagnoses might also include, fibrosarcoma, 
myxoid liposarcoma, embryonal rhabdomyosarcoma, spin-
dle cell squamous carcinoma with cartilaginous metaplasia, 
and chondrometaplasia [6].
Treatment
Surgical resection is regarded as the treatment of choice for 
these tumors. According to the current literature close to 
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one-third of the patients undergo total laryngectomy [41]. 
Radiotherapy does not seem to play an important role, 
though it has been used in the past for recurrent tumors 
unsuitable for surgical treatment. A conservative surgi-
cal approach (open or endoscopic) is often selected in the 
case of low-grade chondrosarcoma with the objective of 
organ preservation [42], but the tumor must be radically 
removed, with a wide margin of normal tissue, and the adja-
cent external perichondrium resected [10]. The majority of 
recurrences observed in the past were probably related to 
piecemeal excisions sparing the external perichondrium. 
Supraglottic laryngectomy is indicated only when the lesion 
is restricted to the supraglottic region [37].
The problem becomes more complex when dealing with 
cricoid lesions, because this cartilage is considered the key-
stone in maintaining an adequate laryngeal airway. When the 
lesion is limited in size and involves less than half of the cri-
coid, conservative removal through a laryngofissure approach 
can be employed. Different techniques have been described 
to reconstruct the laryngeal lumen and to prevent stenosis.
In light of the fact that cervical lymph node metastases 
are rare, neck dissection should be reserved for cases in 
which the clinical picture or imaging techniques suggest 
lymph node involvement. Chemotherapy has not proved to 
be effective for chondrosarcoma of the larynx.
Prognosis
Chondrosarcomas carry a wide range of clinical behavior, 
ranging from locally aggressive non-metastasizing neo-
plasms occasionally invading the thyroid gland, to high-
grade malignancies metastasizing via the blood stream to 
the lungs. Generally speaking, the clinical course of this 
neoplasm depends on the tumor’s degree of differentia-
tion, extension of growth, as well as on the adequacy of 
primary treatment. Grade I chondrosarcomas usually show 
a locally aggressive behavior with a limited propensity for 
metastasis. Metastases are more typical for grade II and 
even more so for grade III lesions.
The current WHO Classification [43] states that the 
1-year, 5-year, and 10-year disease-specific survival rates 
for chondrosarcoma are 96.5%, 88,6%, and 84,8%, respec-
tively. Also, Chin et al. [20] report disease-specific sur-
vival rates for 1, 5, 10, and 20 years to be 97.7%, 91.4%, 
81.8%, and 68.0%, respectively, with no differences when 
correlating 5-year survival rates to location, grade, and 
therapy.
Table 6 contains the salient features of laryngeal chon-
drosarcoma, and Table 7 compares clinical and histo-
pathological features of chondrometaplasia, chondroma 
and chondrosarcoma.
Table 6  Key features of a laryngeal chondrosarcoma
Rare lesions: true incidence difficult to judge, as distinction from chondroma has not always been based on modern criteria
Usually arise in the vicinity of the cricoid cartilage (less often the thyroid cartilage, epiglottis, and body of the arytenoid)
Typically large lesions: 1–6 cm in diameter (usually larger than laryngeal chondromas)
Hyaline cartilage
Cytological features vary from barely perceptible nuclear atypia to readily apparent anaplasia (as a function of the histological type and grade 
of the tumor)
Differential-chondroma
Recurrence may occur following excision, may metastasize (frequency related to histological type and grade
Table 7  Comparison of cartilaginous lesions of the larynx
Chondrometaplasia Chondroma Chondrosarcoma
Presentation Asymptomatic or hoarseness Dyspnea, hoarseness, mass Dyspnea, hoarseness, mass, vocal cord paralysis, 
dysphagia
Common locations Vocal cords, epiglottis Cricoid, thyroid cartilage, 
epiglottis body of the 
arytenoid
Cricoid, thyroid cartilage, epiglottis, body of arytenoid
Size Less than 1 cm Usually 1–3 cm Usually over 3 cm
Fibrocartilage Present Absent Absent
Hyaline cartilage Absent Present Present
Stromal myxoid change Absent Absent May be present
Cellularity Low Low Slight increase to tremendous increase
Cytological atypia Absent Absent Minimal to pronounced
Mitotic figures Absent Absent Rare to numerous
Invasive border Absent Absent Present
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Conclusion
Chondrometaplasia, chondroma and chondrosarcoma 
form the rare entity of laryngeal cartilaginous neoplastic 
lesions. For differential diagnostic purposes both the clini-
cal information as well as an expert opinion of a head and 
neck pathologist on an adequate biopsy sample will be 
needed. Management of these neoplasms should be cen-
tralized to experienced centres.
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